CME/CE

Use the tool below to view all available Global Neurology Academy Series

Treatment of a Broader Population of Patients With DMD
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
1.00 credit
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credit
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
MinuteCE®
Clinical Conundrums in ARIA: When is a Headache Concerning in Patients Prescribed Anti-Aβ mAbs?
1.25 program credits
- James R. Bateman, MD, MPH
- Charles P. Vega, MD
- B. Joy Snider, MD, PhD
1.25 program credits
MinuteCE®
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
1.25 credits 11 episodes
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
1.25 credits 11 episodes
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
MinuteCE®
Clinical Conundrums in ARIA: Evolving Approaches to Mitigate ARIA Risk in Patients Prescribed Anti-Aβ mAbs
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
1.25 program credits
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
MinuteCE®
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
MinuteCE®
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
1.25 program credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
1.25 program credits
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
MinuteCE®
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
1.25 program credits
- James R. Bateman, MD, MPH
- B. Joy Snider, MD, PhD
- Jerome A. Barakos, MD
1.25 program credits
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
CME/CE
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
0.25 credits
- Ahmed Z. Obeidat, MD, PhD
0.25 credits
High-Efficacy DMTs: Transforming MS Care
High-Efficacy DMTs: Transforming MS Care
MinuteCE®
High-Efficacy DMTs: Transforming MS Care
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
MinuteCE®
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
Fluid Biomarkers: Revolutionizing MS Diagnosis
Fluid Biomarkers: Revolutionizing MS Diagnosis
MinuteCE®
Fluid Biomarkers: Revolutionizing MS Diagnosis
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
MinuteCE®
Personalized Care for Diverse MS Populations: Special Populations Equal Special Care
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
Long-Term Safety of DMTs: What We Know and What We Need to Know
Long-Term Safety of DMTs: What We Know and What We Need to Know
MinuteCE®
Long-Term Safety of DMTs: What We Know and What We Need to Know
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
Imaging Biomarkers: MS Progression in Focus
Imaging Biomarkers: MS Progression in Focus
MinuteCE®
Imaging Biomarkers: MS Progression in Focus
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
From Pathology to Practice: The Role of Inflammation in MS Pathology
From Pathology to Practice: The Role of Inflammation in MS Pathology
MinuteCE®
From Pathology to Practice: The Role of Inflammation in MS Pathology
1.00 program credit
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 program credit
MinuteCE®
Patient-Centric Innovations in MS Care: High-Efficacy DMTs, Cognition, and Special Patient Populations
1.00 credit 10 episodes
- Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
- Ahmed Z. Obeidat, MD, PhD
1.00 credit 10 episodes

CME/CE

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

CME/CE

Popular

Title

Share on ReachMD